Vanguard Group Inc - Sep 30, 2025 SCHEDULE 13G/A Report for Karyopharm Therapeutics Inc Common Stock (KPTI)

Filing Manager: VANGUARD GROUP INC
Reporting Manager: The Vanguard Group
Security: Karyopharm Therapeutics Inc Common Stock
Symbol: KPTI
Shares outstanding: 8.69M shares
Disclosed Ownership: 408K shares
Ownership: 4.7%
Form type: SCHEDULE 13G/A
Date filed: 10/30/2025, 03:18 PM
Date of event: Sep 30, 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
The Vanguard Group	4.7%	408K	0	49.4K	Ashley Grim	Head of Global Fund Administration